Investment in health and biotech companies cooled to $90B in 2022

Global medtech and biotech investment fell from $133.8 billion in 2021 to $89.7 billion in 2022, according to investment data from dealroom.co.

Advertisement

The 2021 bull market for medtech investment cooled in 2022 as inflation and economic uncertainty left investors with less capital. 

Despite the market slowdown, 2022 investment numbers still outperformed pre-COVID-19 pandemic investment figures, as 2019 saw $59.7 billion raised.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.